EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities

Ruiye Chen, Yueye Wang, Shiran Zhang, Gabriella Bulloch, Junyao Zhang, Huan Liao, Xianwen Shang, Malcolm Clark, Qingsheng Peng, Zongyuan Ge, Ching‐Yu Cheng, Yuanxu Gao und 2 weitere

MedComm – Future Medicine · 2023-06 · 2 (2)

DOI: 10.1002/mef2.50 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 18.06.2023. Verfasst von Ruiye Chen und 13 weiteren Autor:innen. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 335 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the unprecedented phenomenon of population ageing, studies have increasing captured the heterogeneity within the ageing process. In this context, the concept of “biological age” has been introduced as an integrated measure reflecting the individualized ageing pace. Identifying reliable and robust biomarkers of age is critical for the accurate risk stratification of individuals and exploration into antiageing interventions. Numerous potential biomarkers of ageing have been proposed, spanning from molecular changes and imaging characteristics to clinical phenotypes. In this review, we will start off with a discussion of the development of ageing biomarkers, then we will provide a comprehensive summary of currently identified ageing biomarkers in humans, discuss the rationale behind each biomarker and highlight their accuracy and clinical value with a contemporary perspective. Additionally, we will discuss the challenges, potential applications, and future opportunities in this field. While research on ageing biomarkers has led to significant progress and applications, further investigations are still necessary. We anticipate that future breakthroughs in this field will involve exploring potential mechanisms, developing biomarkers by combining various data sources or employing new technologies, and validating the clinical value of existing and emerging biomarkers through comprehensive collaboration and longitudinal studies.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, R., Wang, Y., Zhang, S., Bulloch, G., Zhang, J., Liao, H., Shang, X., Clark, M., Peng, Q., Ge, Z., Cheng, C., Gao, Y., He, M., & Zhu, Z. (2023). Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities. MedComm – Future Medicine, 2(2). https://doi.org/10.1002/mef2.50

Vancouver

Chen R, Wang Y, Zhang S, Bulloch G, Zhang J, Liao H, et al. Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities. MedComm – Future Medicine. 2023;2(2). doi:10.1002/mef2.50

BibTeX
@article{Chen2023,
  author = {Chen, Ruiye and Wang, Yueye and Zhang, Shiran and Bulloch, Gabriella and Zhang, Junyao and Liao, Huan and Shang, Xianwen and Clark, Malcolm and Peng, Qingsheng and Ge, Zongyuan and Cheng, Ching‐Yu and Gao, Yuanxu and He, Mingguang and Zhu, Zhuoting},
  title = {Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities},
  journal = {MedComm – Future Medicine},
  year = {2023},
  volume = {2},
  number = {2},
  doi = {10.1002/mef2.50}
}
Kostenlos starten →